Schizophrenia & Other Psychotic Disorders
Podcasts
Steps to take when a patient develops tardive dyskinesia
Stanley N. Caroff, MD
Evidence-Based Reviews
Is there a rational management strategy for tardive dyskinesia?
Decisions should be based on the course of TD and effective control of psychotic symptoms
From the Editor
Quo vadis, psychopharmacology?
Innovation in psychopharmacology depends on overcoming multiple challenges that stifle drug discovery and development
Commentary
Delirium and benzodiazepines
Pearls
Reducing clozapine-induced hypersalivation
Antimuscarinic medications and chewing gum can help prevent excess saliva from disrupting a patient’s life
Savvy Psychopharmacology
Is there a link between aripiprazole and treatment-emergent psychosis?
News
Off-Label Use of Atypical Antipsychotics Minimally Effective
Major Finding: Three atypical antipsychotic drugs are minimally effective for dementia, one is effective for generalized anxiety disorder, and one...
News
Don't Rule Out Marijuana as Trigger for Schizophrenia
News
Antipsychotics Linked to Metabolic Syndrome Spike in Children
Major Finding: The risk for the developing metabolic syndrome in children and adolescents increases sharply between 3-12 months of antipsychotic...
Conference Coverage
Metabolic Signature Emerging in Schizophrenia
Major Finding: Within 13 schizophrenia genes associated with five metabolites, 52% of the networks were related to neurodevelopment and learning...